EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Three Decades of Taxanes: Exploring the Next Frontier

Rita I. L. Catarino, Maria Fernanda C. Leal, Adriana M. Pimenta, Maria Renata S. Souto, Francisco A. M. Silva

Scientia Pharmaceutica · 08.04.2026 · 94 (2) · 29

DOI: 10.3390/scipharm94020029 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Scientia Pharmaceutica, online erschienen am 08.04.2026. Verfasst von Rita I. L. Catarino und 4 weiteren Autor:innen. Die Arbeit nennt 182 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Taxanes, such as paclitaxel and docetaxel, are microtubule-stabilizing agents widely used in oncology, either as monotherapy or in combination regimens. While highly effective, these first-generation taxanes face important limitations, including significant toxicity, reduced water solubility, and the emergence of multidrug resistance. To address these challenges, semi-synthetic taxoids have been developed, aiming to improve pharmacological profiles and overcome therapeutic barriers. Central to these efforts is the understanding of structure-activity relationships, which guides the rational design of taxane analogues with enhanced efficacy and safety. This review explores recent advances in taxoid development, highlights findings from clinical trials, and evaluates how these new agents compare with traditional taxanes in terms of therapeutic potential and tolerability. While novel delivery systems offer improved outcomes with existing drugs, the development of new taxane analogues remains a promising approach to address drug resistance, albeit with challenges related to toxicity, high costs, and historically low success rates in drug development. Furthermore, taxanes are already used in certain cardiovascular conditions and show emerging potential in neurodegenerative diseases, although current evidence remains largely limited to preclinical or early-phase clinical studies. These developments mark an important evolution in the field and offer new opportunities for future therapeutic strategies.

Zitieren

APA

Catarino, R. I. L., Leal, M. F. C., Pimenta, A. M., Souto, M. R. S., & Silva, F. A. M. (2026). Three Decades of Taxanes: Exploring the Next Frontier. Scientia Pharmaceutica, 94(2), 29. https://doi.org/10.3390/scipharm94020029

Vancouver

Catarino RIL, Leal MFC, Pimenta AM, Souto MRS, Silva FAM. Three Decades of Taxanes: Exploring the Next Frontier. Scientia Pharmaceutica. 2026;94(2):29. doi:10.3390/scipharm94020029

BibTeX
@article{Catarino2026,
  author = {Catarino, Rita I. L. and Leal, Maria Fernanda C. and Pimenta, Adriana M. and Souto, Maria Renata S. and Silva, Francisco A. M.},
  title = {Three Decades of Taxanes: Exploring the Next Frontier},
  journal = {Scientia Pharmaceutica},
  year = {2026},
  volume = {94},
  number = {2},
  pages = {29},
  doi = {10.3390/scipharm94020029}
}
Kostenlos starten →